AstaReal wins NutraIngredients-Asia Award for first clinical trial on children’s digital eye health
The recognition comes for conducting the world’s first clinical trial on digital eye health in children, with the study published in Advances in Therapy.
The trial demonstrated that astaxanthin supplementation can effectively reduce both chronic and acute digital eye strain whilst enhancing objective measures of visual performance.
In the clinical study, school-aged children received a daily dose of 4 mg of astaxanthin (AstaReal) for 84 days.
The findings indicate a significant improvement in chronic digital eye strain in the astaxanthin group compared with placebo, demonstrating a 20% greater reduction in the CVS (Computer Vision Syndrome) symptoms score by the end of the study.
The results also showed a 27% improvement in visual fatigue (acute digital eye strain) as well as improved stereopsis and pupillary light reflexes after the trial period.
Paper (paywalled):
Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double-Blind Placebo-Controlled Trial
Yeah, they pulled out a small change in one of the parameters. And the placebo group also seemed to get better over time too.
I thought lutein and zeaxanthin were the go-to for eye health, eye strain etc. Though Astaxanthin is a powerful antioxidant, so I guess it’s plausible to be helpful here.
Exactly correct. Lutein and zeaxanthin (and mesozeaxanthin) are most absorbed by tissues in the eye and most biologically significant. Astaxanthin is absorbed too, but to a much smaller extent, and doesn’t seem to do anything beyond what the former accomplish. I posted a ton of papers in various threads on all these carrotenoids and the eye.
